はじめての方へショーケース価格
  1. 米国企業
  2. ALNYLAM PHARMACEUTICALS, INC.

ALNYLAM PHARMACEUTICALS, INC.ALNY

時価総額
$190.5億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2010年
12月31日		2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Product--------131673626628941,241
Royalty revenue-----------1841
Collaborations-------------546
Royalty revenue-----------1841
Total revenues100-------752204938441,0371,828
Product--------131673626628941,241
Royalty revenue-----------1841
Collaborations-------------546
Royalty revenue-----------1841
Total revenues100-------752204938441,0371,828
Cost of goods sold--------22578115140268
Cost of collaborations and royalties-----------252942
Research and development10699871131902763823915056556557928831,004
Selling, general and administrative--------382479588621771796
Total operating costs and expenses--------8901,1591,3211,5531,8222,110
Loss from operations-44-55-129-93-405-296-425-500-815-939-828-709-785-282
Interest expense----------84143156121
Other expense, net6-10-0206-341146-2-109-126
Interest income211-------122-96
Loss on the extinguishment of debt-------------77-
Other expense, net6-10-0206-341146-2-109-126
Total other expense, net1-3131461495454-27-143-342-151
Loss on the extinguishment of debt-------------77-
Total other expense, net1-3131461495454-27-143-342-151
Loss before income taxes-43-58-117-92-401-290-410--761-885-856-852-1,127-434
Provision for income taxes1--11-3----113147
Net loss-44-58-106-89-360-290-410-491-761-886-858-853-1,131-440
Earnings Per Share, Basic------------7.2-9.3-3.52
Earnings Per Share, Diluted------------7.2-9.3-3.52
Net income (loss)-44-58-106-89-360-290-410-491-761-886-858-853-1,131-440
Unrealized gain (loss) on marketable securities0-116431-44-31-3110-2-811
Foreign currency translation gain (loss)----------0-711-512
Defined benefit pension plans, net of tax---------40-1-22
Total other comprehensive income (loss)-----------10-1121
Comprehensive loss-44-59-90-85-331-334-448-492-760-889-865-842-1,143-419
Product--------131673626628941,241
Royalty revenue-----------1841
Collaborations-------------546
Royalty revenue-----------1841
Total revenues100-------752204938441,0371,828
Product--------131673626628941,241
Royalty revenue-----------1841
Collaborations-------------546
Royalty revenue-----------1841
Total revenues100-------752204938441,0371,828
Cost of goods sold--------22578115140268
Cost of collaborations and royalties-----------252942
Research and development10699871131902763823915056556557928831,004
Selling, general and administrative--------382479588621771796
Total operating costs and expenses--------8901,1591,3211,5531,8222,110
Loss from operations-44-55-129-93-405-296-425-500-815-939-828-709-785-282
Interest expense----------84143156121
Other expense, net6-10-0206-341146-2-109-126
Interest income211-------122-96
Loss on the extinguishment of debt-------------77-
Other expense, net6-10-0206-341146-2-109-126
Total other expense, net1-3131461495454-27-143-342-151
Loss on the extinguishment of debt-------------77-
Total other expense, net1-3131461495454-27-143-342-151
Loss before income taxes-43-58-117-92-401-290-410--761-885-856-852-1,127-434
Provision for income taxes1--11-3----113147
Net loss-44-58-106-89-360-290-410-491-761-886-858-853-1,131-440
Earnings Per Share, Basic------------7.2-9.3-3.52
Earnings Per Share, Diluted------------7.2-9.3-3.52
Net income (loss)-44-58-106-89-360-290-410-491-761-886-858-853-1,131-440
Unrealized gain (loss) on marketable securities0-116431-44-31-3110-2-811
Foreign currency translation gain (loss)----------0-711-512
Defined benefit pension plans, net of tax---------40-1-22
Total other comprehensive income (loss)-----------10-1121
Comprehensive loss-44-59-90-85-331-334-448-492-760-889-865-842-1,143-419